Talmud PJ, Holmes MV (2015)
Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart Disease
Arterioscler Thromb Vasc Biol 35: 2281

Casas JP, Ninio E, Panayiotou A, Palmen J, Cooper JA, Ricketts SL, Sofat R, Nicolaides AN, Corsetti JP, Fowkes FG, Tzoulaki I, Kumari M, Brunner EJ, Kivimaki M, Marmot MG, Hoffmann MM, Winkler K, Marz W, Ye S, Stirnadel HA, Boekholdt SM, Khaw KT, Humphries SE, Sandhu MS, Hingorani AD, Talmud PJ (2010)
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry
Circulation 121: 2284

Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, Whittall R, Lee PJ, Lins L, Delsaux N, Nierman M, Kuivenhoven JA, Kastelein JJ, Vrablik M, Olivecrona G, Schneider WJ, Heeren J, Humphries SE, Talmud PJ (2008)
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding
Arterioscler Thromb Vasc Biol 28: 1866

Humphries SE, Cooper JA, Talmud PJ, Miller GJ (2007)
Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men
Clinical Chemistry 53: 8

Talmud PJ, Flavell DM, Alfakih K, Cooper JA, Balmforth AJ, Sivananthan M, Montgomery HE, Hall AS, Humphries SE (2007)
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease
Clinical Science (Lond) 112: 617

Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, Talmud PJ (2007)
Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training
Nutr Metab Cardiovasc Dis 17: 24

Flavell DM, Wootton PT, Myerson SG, World MJ, Pennell DJ, Humphries SE, Talmud PJ, Montgomery HE (2006)
Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth
J Mol Med (Berl) 84: 126

Talmud PJ, Palmen J, Wolf AM, Beisiegel U (2005)
Investigation into the role of the hormone sensitive lipase -60C>G promoter variant in morbid obesity
Nutr Metab Cardiovasc Dis 15: 31

Waterworth DM, Jansen H, Nicaud V, Humphries SE, Talmud PJ (2005)
Interaction between insulin (VNTR) and hepatic lipase (LIPC-514C>T) variants on the response to an oral glucose tolerance test in the EARSII group of young healthy men
Biochimica & Biophysica Acta 1740: 375

Talmud PJ, Stephens JW (2004)
Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk
Diabetes Obes Metab 6: 1

Abuzeid AM, Hawe E, Humphries SE, Talmud PJ (2003)
Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe
Atherosclerosis 168: 283

Talmud PJ, Hawe E, Robertson K, Miller GJ, Miller NE, Humphries SE (2002)
Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men
Ann Hum Genet 66: 111

Hubacek JA, Waterworth DM, Pitha J, Humphries SE, Talmud PJ, Poledne R (2001)
Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population
Physiol Res 50: 345

Hall S, Talmud PJ, Cook DG, Wicks PD, Rothwell MJ, Strazzullo P, Sagnella GA, Cappuccio FP (2000)
Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study
Genet Epidemiol 18: 203

Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ (1999)
The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II
Arterioscler Thromb Vasc Biol 19: 303

Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ (1998)
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS)
Arterioscler Thromb Vasc Biol 18: 526

Talmud PJ, Hall S, Holleran S, Ramakrishnan R, Ginsberg HN, Humphries SE (1998)
LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics
J Lipid Res 39: 1189

Fisher RM, Humphries SE, Talmud PJ (1997)
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis
Atherosclerosis 135: 145

Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, Faergeman O (1997)
Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies
Circulation 96: 733

Hall S, Chu G, Miller G, Cruickshank K, Cooper JA, Humphries SE, Talmud PJ (1997)
A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro
Arterioscler Thromb Vasc Biol 17: 1969

Mailly F, Palmen J, Muller DP, Gibbs T, Lloyd J, Brunzell J, Durrington P, Mitropoulos K, Betteridge J, Watts G, Lithell H, Angelico F, Humphries SE, Talmud PJ (1997)
Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy
Hum Mutat 10: 465

Humphries SE, Talmud PJ, Cox C, Sutherland W, Mann J (1996)
Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge
Qjm 89: 671

Mailly F, Fisher RM, Nicaud V, Luong LA, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE (1996)
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study
Atherosclerosis 122: 21